OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(9)
Publication Date
Release Date
2023
(2)
2021
(2)
2026
(1)
2024
(1)
2020
(1)
2019
(1)
2018
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation.
Not available
S-EPMC8298945
|
biostudies-literature
Cite
An interconnected data infrastructure to support large-scale rare disease research.
Not available
S-EPMC11413801
|
biostudies-literature
Cite
Solving unsolved rare neurological diseases-a Solve-RD viewpoint.
Not available
S-EPMC8440537
|
biostudies-literature
Cite
Clinical, genetic, epidemiologic, evolutionary, and functional delineation of
TSPEAR
-related autosomal recessive ectodermal dysplasia 14.
Not available
S-EPMC10064225
|
biostudies-literature
Cite
Deep learning enhanced ALPS reveals genetic and environmental factors of brain glymphatic function.
Not available
S-EPMC12878677
|
biostudies-literature
Cite
Surgical site infection after gastrointestinal surgery in children: an international, multicentre, prospective cohort study.
Not available
S-EPMC7716674
|
biostudies-literature
Cite
Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study.
Not available
S-EPMC5910057
|
biostudies-literature
Cite
Global variation in anastomosis and end colostomy formation following left-sided colorectal resection.
Not available
S-EPMC6921967
|
biostudies-literature
Cite
Use of Telemedicine for Postdischarge Assessment of the Surgical Wound: International Cohort Study, and Systematic Review With Meta-analysis.
Not available
S-EPMC10174106
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets